PHARMALOG Institut für klinische Forschung GmbH

Company

    • Company type:
      • Service Provider
    • Year founded:
    • 1983
    • Employees (at the site):
    • 30
    • Turnover range:
    • <5m EUR
    • Products/services:
    • Development of Clinical Trials (Phases I, II-IV) for the Pharma-Industry

    • Core competencies:
    • Pharmalog acts as a European full service CRO with an excellent reputation in clinical trials Phase (I), II, III, IV since 1983. Our staff of 30 colleagues (including 7 M.D., central and field based monitors) conducts clinical trials and post marketing surveillances in Germany, all EU-countries and Eastern Europe (Hungary, Czech Republic, Poland, Slovakia, Slowenia, Croatia, Russia, Jugoslawia), using our large pool of investigators (9,800 investigators in clinics and practices). Special advantages of studies in Eastern Europe are: fast patient recruitment, motivated investigators, lower costs and our local monitors as native speakers. We have performed more than 300 clinical trials in all medical indications for medicinal products and medical devices / biotechnology products according to ICH- and FDA-Standards for 50 national and international pharmaceutical companies. We offer full service or modular approach (e.g. monitoring, data management / statistics) and reasonable pricing due

    • Language skills:
    • English
      French
      German
      Ukrainian
    • Key Tech / section:
      • Biotechnology: Contract research (CROs) and contract manufacturing (CMOs)
    • Industries NACE:
      • 72: Scientific research and development
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Dipl.-Stat. Holger Stammer (Mr.)
      - Management